Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of High Versus Standard Enteral Protein Provision on Functional Recovery Following Intensive Care Admission: a Randomized Controlled, Multicenter, Parallel Group Trial in Mechanically Ventilated, Critically Ill Patients

NCT04633421 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT04633421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04633421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of High Versus Standard Enteral Protein Provision on Functional Recovery Following Intensive Care Admission: a Randomized Controlled, Multicenter, Parallel Group Trial in Mechanically Ventilated, Critically Ill Patients
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
November 19, 2020
Completion date
October 3, 2023
Enrollment
935 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, intensive care unit acquired weakness